Protein linked to invasive spread of triple-negative breast cancer may lead to targeted therapies

February 26, 2014, Agency for Science, Technology and Research (A*STAR), Singapore
Analyzing the gene expression profiles of triple-negative breast cancer (TNBC) tumors has highlighted a protein tyrosine phosphatase — encoded by the UBASH3B gene — as a potential target for therapy. Credit: Duncan Smith/Photodisc/Thinkstock

Triple-negative breast cancer (TNBC) is one of the most aggressive forms of the disease and affects almost one in seven of the 1.5 million women diagnosed with breast cancer worldwide each year. TNBC tumors are missing three key proteins that can be targeted by conventional breast cancer therapies. Consequently, patients often relapse after treatment and suffer metastasis—the spread of cancerous cells and tumor growth to other parts of the body.

Targeted therapy for TNBC is limited by a lack of understanding of the molecular mechanisms behind this form of the disease. Now, Qiang Yu and co-workers at the A*STAR Genome Institute of Singapore, together with scientists from Singapore and the United States, have discovered that a protein known as a —encoded by the UBASH3B gene—is overexpressed in one third of TNBC patients and could form the basis of a for TNBC1.

"Patients with TNBC often have a worse prognosis than other types, yet there is no drug target for therapy," states Yu. "Therefore, we began an integrated genetic investigation to uncover the molecular processes behind the disease."

Using gene array technology, Yu and her team analyzed gene expression in human breast cancer cell lines and both TNBC and non-TNBC tumors in order to pinpoint genetic differences. After establishing the main genes affecting disease outcome, the researchers systematically knocked down the expression of each. Their results showed that the UBASH3B-encoded protein—a T-cell receptor repressor—was overexpressed in the most invasive TNBC cell lines.

"We discovered that UBASH3B modulates the protein expression of the epidermal growth factor receptor, promoting invasion and allowing TNBC to take a stronger hold," explains Yu. "In addition, UBASH3B is usually inhibited by an anti-invasive microRNA, but this effect is often downregulated in TNBC, which aids phosphatase overexpression."

The team found that a high level of UBASH3B expression in TNBC patients is directly linked to a poor survival rate. By knocking down UBASH3B in TNBC-affected mice, Yu's team was able to substantially increase the life expectancy of the mice and reduce their chance of metastasis.

Further clarification of TNBC molecular mechanisms is required but Yu is confident that UBASH3B could prove crucial in the development of TNBC-targeted therapies. "UBASH3B could be a potential drug target, and equally it could be used as a biomarker to predict the outcome of TNBC" says Yu. "We will continue to pursue a more clinical validation to verify these approaches."

Explore further: Scientists discover new drug targets for aggressive breast cancer

More information: Lee, S. T., Feng, M., Wei, Y., Li, Z., Qiao, Y. et al. "Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis." Proceedings of the National Academy of Sciences USA 110, 11121–11126 (2013). dx.doi.org/10.1073/pnas.1300873110

Related Stories

Scientists discover new drug targets for aggressive breast cancer

July 26, 2013
Scientists at A*STAR's Genome Institute of Singapore (GIS) led in a study that has identified genes that are potential targets for therapeutic drugs against aggressive breast cancer. These findings were reported in the July ...

A form of small pox virus shows potential for treating triple-negative breast cancer

October 1, 2012
Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City have shown that a new vaccinia virus, acting as both an oncolytic and anti-angiogenic agent, can enter and kill triple-negative breast cancer ...

Research findings could lead to life-saving treatments to fight tumor metastasis

January 16, 2014
A team of researchers from the Cleveland Clinic and Case Western Reserve School of Medicine have identified critical complex mechanisms involved in the metastasis of deadly "triple negative" breast cancers (TNBC). These tumors ...

Study role testosterone may play in triple negative breast cancer

March 23, 2012
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. ...

Engineered virus is effective against triple negative breast cancer cells

January 30, 2014
Scientists have discovered a potential cure for one of the most aggressive and least treatable forms of breast cancer called "triple negative breast cancer." In laboratory experiments involving human cancer cells, scientists ...

Different subtypes of triple-negative breast cancer respond to different therapies

June 27, 2011
Vanderbilt-Ingram Cancer Center researchers have identified six subtypes of an aggressive and difficult-to-treat form of breast cancer, called "triple-negative breast cancer (TNBC)."

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.